ARQULE (NASDAQ:ARQL)
3.30
+0.09 (2.80%)
| ARQULE (NASDAQ:ARQL) Delayed : |
| Previous Close |
$3.21 |
|
52 Week High |
$6.38 |
|
| Open |
$3.19 |
|
52 Week Low |
$2.22 |
| Day High |
$3.32 |
|
P/E |
N/A |
| Day Low |
$3.17 |
|
EPS |
$-0.82 |
| Volume |
144,957 |
|
|
|
| More ARQL Info:
Chart
SEC Filings
Profile
Historical
Options
|
View All ReportsStreetInsider.com Reports on ARQL
-
Nov 5, 2009 08:32 AM
ArQule (ARQL) Posts Q3 Loss of $0.18, Beats Estimates; Reaffirms Guidance
-
Nov 4, 2009 02:42 PM
Trading Radar for 11/05: Starbucks (SBUX), CBS Corp. (CBS), CVS (CVS), Toyota (TM), Thomson Reuters (TRI)
-
Oct 13, 2009 08:29 AM
UBS Upgrades ArQule (ARQL) Two Notches to Buy
-
Aug 6, 2009 10:36 AM
ArQule (ARQL) Reports Q2 Loss of $0.19, Beats by 4c; Affirms FY09 Guidance
-
Jul 23, 2009 10:01 AM
Needham Comments on "Who's Next" In Biotech After Bristol-Myers (BMY) Buys Medarex (MEDX)
View All Reports
-
Nov 16, 2009 12:30PM
Drug Discovery Capabilities of ArQule Kinase Inhibitor Platform Presented at AACR-NCI-EORTC Conference
-
Nov 10, 2009 08:30AM
ArQule, Inc. to Present at Lazard Capital Markets Sixth Annual Healthcare Conference on November 17, 2009
-
Nov 5, 2009 07:00AM
ArQule Announces Third Quarter Fiscal 2009 Results
-
Oct 29, 2009 08:30AM
ArQule, Inc. to Report Third Quarter 2009 Financial Results on Thursday, November 5, 2009
-
Oct 27, 2009 04:00PM
ArQule, Inc. to Present at Oppenheimer 20th Annual Healthcare Conference on November 3, 2009
View All Press Releases
StreetInsider Reports on ARQL by Category
Comments on ARQL
No comments are currently available.